To achieve sufficient insulin activity at the liver without raisingperipheral insulin levels excessively (with resulting risk of hypoglycemia), the nextgeneration of once-weekly basal insulins need to control peripheral exposure to mimicthe hepatic to peripheral gradient of endogenous insulin. The gene discussed is INS; the disease is Hypoglycemia.